药物对比
Tirzepatide vs Acarbose
Tirzepatide（Mounjaro）与Acarbose（Precose）治疗2型糖尿病对比：双重GIP/GLP-1注射剂与口服α-葡萄糖苷酶抑制剂。Tirzepatide在A1C和体重方面更优；Acarbose是较温和的口服选择。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes comparing an injectable dual GIP/GLP-1 agonist against a traditional oral alpha-glucosidase inhibitor for glycemic control and weight management.
结论
Tirzepatide typically delivers greater A1C reduction and weight loss than Acarbose, but administration route and safety profile influence individual suitability.
全部药物对比